The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world disease burden for patients (pts) with myelofibrosis (MF) treated with ruxolitinib (RUX).
 
Aaron Thomas Gerds
Consulting or Advisory Role - Apexx Oncology; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Galecto; Kartos Therapeutics; Pfizer; Promedior
Research Funding - Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Imago Biosciences; Incyte; Sierra Oncology
 
Jonathan Kish
Employment - Cardinal Health
Stock and Other Ownership Interests - Cardinal Health
 
Kejal Parikh
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Djibril Liassou
No Relationships to Disclose
 
Talia Miller
Employment - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health
 
Ronda Copher
Employment - Celgene/Bristol-Myers Squibb
Stock and Other Ownership Interests - Celgene/Bristol-Myers Squibb
Research Funding - Celgene/Bristol-Myers Squibb